Kayexalate
Modify Date: 2024-04-03 20:15:10
Kayexalate structure
|
Common Name | Kayexalate | ||
|---|---|---|---|---|
| CAS Number | 37349-16-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of KayexalateKayexalate, a cation-exchange resin, is an orally active plasma potassium inhibitor. Kayexalate can be used in the research of hyperkalemia[1][2]. |
| Name | Kayexalate |
|---|
| Description | Kayexalate, a cation-exchange resin, is an orally active plasma potassium inhibitor. Kayexalate can be used in the research of hyperkalemia[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Propiomazine (5 g/kg, oral gavage) lowers serum Li concentrations in CD-1 mice[2]. Propiomazine (5 g/kg, oral gavage) reduces serum K concentrations in CD-1 mice[3]. Animal Model: CD-1 mice given with LiCl (125 mg/kg, i.v.)[2] Dosage: 5 g/kg Administration: Oral gavage, at 20, 40, 90, 150, and 210 minutes after LiCl challenge. Result: Effectively enhanced the elimination of intravenously administered Li. |
| No Any Chemical & Physical Properties |